Despite a dominant position in analytical instruments, Waters Corporation faces headwinds from a slowing Chinese market and elevated debt. We examine the investment thesis for the life sciences tools provider, weighing its recurring revenue model against current valuation concerns.
As DoorDash trades near $205, analysts debate whether its integrated logistics platform, likened to a modern utility, justifies its premium multiples amid expansion into groceries and international markets.
Despite recent stock pressure from its CRM platform migration, Veeva Systems' deep integration in life sciences workflows, robust financials, and expanding AI product suite present a compelling long-term investment case, analysts argue.
Brussels-based clean transport group Transport & Environment warns that the European Commission's proposed easing of 2035 emissions targets may allow combustion-engine cars to make up half of new sales, marking a significant retreat from earlier climate ambitions.
Apple's historic Q1 earnings, fueled by unprecedented iPhone demand, sent its stock on a wild ride. While the results dazzled Wall Street, muted guidance on memory cost pressures and questions about its AI roadmap tempered the celebration.
A landmark all-stock merger between Devon Energy and Coterra Energy is set to create the nation's second-largest independent oil and gas producer, promising significant cost savings and enhanced shareholder returns in a consolidating energy market.
Analysts have slashed Senseonics Holdings' 12-month price target by 40%, signaling heightened caution on the medical device maker's execution path following its stock split, despite maintaining a bullish long-term revenue model.
InSilico Medicine Cayman TopCo's shares have rocketed over 60% in a month, forcing investors to scrutinize whether its AI-driven drug discovery promise can justify the momentum, especially against a backdrop of persistent losses and a negative book value.
BioNTech appoints Kylie Jimenez as its first Chief People Officer, a strategic move aimed at building the organizational and cultural backbone for its ambitious transition into a multi-product oncology company by 2030.
After a period of significant volatility, Neogen Corporation (NEOG) is showing signs of a sustainable operational turnaround under new leadership, with its latest quarterly results beating expectations and prompting a rare guidance upgrade.
With a key FDA decision on its non-nicotine therapy cytisinicline expected by mid-2026, Achieve Life Sciences (ACHV) is drawing bullish attention for its potential to address a massive unmet need in smoking cessation and tap into a newly opened market void.
While Wall Street obsesses over GLP-1 weight-loss drugs, Novo Nordisk's foundational diabetes business continues to deliver robust growth and exceptional returns on assets, presenting a durable investment thesis often overshadowed by the obesity narrative.
AbbVie's $2.1 billion acquisition of Capstan Therapeutics signals a strategic pivot towards next-generation immunology treatments. The move aims to secure future revenue streams as the company navigates the post-Humira era, with analysts highlighting the transformative potential of its in vivo CAR-T platform.
As AI infrastructure spending accelerates, Arista Networks (ANET) is drawing investor attention with its debt-free balance sheet and critical role in cloud networking. Despite premium valuations, bulls argue its financial fortress and recurring software revenue justify the price, with a $163 price target signaling further upside.
The banking, financial services, and insurance (BFSI) sector is poised for a pivotal transformation. As the initial wave of AI and cloud experimentation subsides, 2026 is emerging as the year the industry moves decisively toward operationalizing technology with robust governance, explainability, and compliance at its core.
Liberty Global, Europe's cable and mobile giant, has signed a five-year strategic partnership with Google Cloud to integrate Gemini AI and cloud tools across its operations, aiming to enhance TV platforms, automate services, and explore new revenue streams.
With prized Burmese teak off-limits due to sanctions and old-growth stocks dwindling, the luxury yacht industry is accelerating its search for viable—and sustainable—alternatives, from engineered woods to advanced synthetics.
Investors seeking stability in volatile markets often turn to consumer staples ETFs. We analyze the strategic divergence between Fidelity's broad, low-cost approach and Invesco's targeted, factor-driven fund to determine which might better serve a defensive portfolio.
Elon Musk consolidates his space and artificial intelligence ventures, with SpaceX acquiring xAI to form a private sector titan valued over a trillion dollars, aiming to solve AI's energy crisis by moving compute to space.
In an exclusive interview, GeneDx CEO Katherine Stueland details how rapid genomic testing is transforming pediatric care, slashing diagnosis times from years to days and building a data-driven bridge to future therapies.
